Antimicrobial effects on swine gastrointestinal microbiota and their accompanying antibiotic resistome

Research output: Contribution to journalReview article

Abstract

Antimicrobials are the most commonly prescribed drugs in the swine industry. While antimicrobials are an effective treatment for serious bacterial infections, their use has been associated with major adverse effects on health. It has been shown that antimicrobials have substantial direct and indirect impacts on the swine gastrointestinal (GI) microbiota and their accompanying antimicrobial resistome. Antimicrobials have also been associated with a significant public health concern through selection of resistant opportunistic pathogens and increased emergence of antimicrobial resistance genes (ARGs). Since the mutualistic microbiota play a crucial role in host immune regulation and in providing colonization resistance against potential pathogens, the detrimental impacts of antimicrobial treatment on the microbiota structure and its metabolic activity may lead to further health complications later in life. In this review, we present an overview of antimicrobial use in the swine industry and their role in the emergence of antimicrobial resistance. Additionally, we review our current understanding of GI microbiota and their role in swine health. Finally, we investigate the effects of antimicrobial administration on the swine GI microbiota and their accompanying antibiotic resistome. The presented data is crucial for the development of robust non-antibiotic alternative strategies to restore the GI microbiota functionality and guarantee effective continued use of antimicrobials in the livestock production system.

Original languageEnglish (US)
Article number1035
JournalFrontiers in Microbiology
Volume10
Issue numberMAY
DOIs
StatePublished - Jan 1 2019

Fingerprint

Swine
Anti-Bacterial Agents
Microbiota
Industry
Health
Livestock
Bacterial Infections
Public Health
Gastrointestinal Microbiome
Pharmaceutical Preparations
Genes

Keywords

  • Antimicrobial
  • Gastrointestinal
  • Microbiota
  • Resistome
  • Swine

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

Antimicrobial effects on swine gastrointestinal microbiota and their accompanying antibiotic resistome. / Zeineldin, Mohamed; Aldridge, Brian Michael; Lowe, James F.

In: Frontiers in Microbiology, Vol. 10, No. MAY, 1035, 01.01.2019.

Research output: Contribution to journalReview article

@article{fa3692ba2cef41ccb593c39040564c6b,
title = "Antimicrobial effects on swine gastrointestinal microbiota and their accompanying antibiotic resistome",
abstract = "Antimicrobials are the most commonly prescribed drugs in the swine industry. While antimicrobials are an effective treatment for serious bacterial infections, their use has been associated with major adverse effects on health. It has been shown that antimicrobials have substantial direct and indirect impacts on the swine gastrointestinal (GI) microbiota and their accompanying antimicrobial resistome. Antimicrobials have also been associated with a significant public health concern through selection of resistant opportunistic pathogens and increased emergence of antimicrobial resistance genes (ARGs). Since the mutualistic microbiota play a crucial role in host immune regulation and in providing colonization resistance against potential pathogens, the detrimental impacts of antimicrobial treatment on the microbiota structure and its metabolic activity may lead to further health complications later in life. In this review, we present an overview of antimicrobial use in the swine industry and their role in the emergence of antimicrobial resistance. Additionally, we review our current understanding of GI microbiota and their role in swine health. Finally, we investigate the effects of antimicrobial administration on the swine GI microbiota and their accompanying antibiotic resistome. The presented data is crucial for the development of robust non-antibiotic alternative strategies to restore the GI microbiota functionality and guarantee effective continued use of antimicrobials in the livestock production system.",
keywords = "Antimicrobial, Gastrointestinal, Microbiota, Resistome, Swine",
author = "Mohamed Zeineldin and Aldridge, {Brian Michael} and Lowe, {James F}",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fmicb.2019.01035",
language = "English (US)",
volume = "10",
journal = "Frontiers in Microbiology",
issn = "1664-302X",
publisher = "Frontiers Media S. A.",
number = "MAY",

}

TY - JOUR

T1 - Antimicrobial effects on swine gastrointestinal microbiota and their accompanying antibiotic resistome

AU - Zeineldin, Mohamed

AU - Aldridge, Brian Michael

AU - Lowe, James F

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Antimicrobials are the most commonly prescribed drugs in the swine industry. While antimicrobials are an effective treatment for serious bacterial infections, their use has been associated with major adverse effects on health. It has been shown that antimicrobials have substantial direct and indirect impacts on the swine gastrointestinal (GI) microbiota and their accompanying antimicrobial resistome. Antimicrobials have also been associated with a significant public health concern through selection of resistant opportunistic pathogens and increased emergence of antimicrobial resistance genes (ARGs). Since the mutualistic microbiota play a crucial role in host immune regulation and in providing colonization resistance against potential pathogens, the detrimental impacts of antimicrobial treatment on the microbiota structure and its metabolic activity may lead to further health complications later in life. In this review, we present an overview of antimicrobial use in the swine industry and their role in the emergence of antimicrobial resistance. Additionally, we review our current understanding of GI microbiota and their role in swine health. Finally, we investigate the effects of antimicrobial administration on the swine GI microbiota and their accompanying antibiotic resistome. The presented data is crucial for the development of robust non-antibiotic alternative strategies to restore the GI microbiota functionality and guarantee effective continued use of antimicrobials in the livestock production system.

AB - Antimicrobials are the most commonly prescribed drugs in the swine industry. While antimicrobials are an effective treatment for serious bacterial infections, their use has been associated with major adverse effects on health. It has been shown that antimicrobials have substantial direct and indirect impacts on the swine gastrointestinal (GI) microbiota and their accompanying antimicrobial resistome. Antimicrobials have also been associated with a significant public health concern through selection of resistant opportunistic pathogens and increased emergence of antimicrobial resistance genes (ARGs). Since the mutualistic microbiota play a crucial role in host immune regulation and in providing colonization resistance against potential pathogens, the detrimental impacts of antimicrobial treatment on the microbiota structure and its metabolic activity may lead to further health complications later in life. In this review, we present an overview of antimicrobial use in the swine industry and their role in the emergence of antimicrobial resistance. Additionally, we review our current understanding of GI microbiota and their role in swine health. Finally, we investigate the effects of antimicrobial administration on the swine GI microbiota and their accompanying antibiotic resistome. The presented data is crucial for the development of robust non-antibiotic alternative strategies to restore the GI microbiota functionality and guarantee effective continued use of antimicrobials in the livestock production system.

KW - Antimicrobial

KW - Gastrointestinal

KW - Microbiota

KW - Resistome

KW - Swine

UR - http://www.scopus.com/inward/record.url?scp=85068590812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068590812&partnerID=8YFLogxK

U2 - 10.3389/fmicb.2019.01035

DO - 10.3389/fmicb.2019.01035

M3 - Review article

AN - SCOPUS:85068590812

VL - 10

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

SN - 1664-302X

IS - MAY

M1 - 1035

ER -